908 DevicesMASS +2.87%70 FCF Margin % is 8.71% as of Mar. 2026. GuruFocus rates MASS with a GF Score™ of 70/100 and a GF Value™ of $6.91 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 815 Medical Devices & Instruments companies, 908 Devices ranks worse than 68.59% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 908 Devices's Free Cash Flow for the
three
months ended in Mar. 2026 was $1.17 Mil. 908 Devices's Revenue for the
three
months ended in Mar. 2026 was $13.38 Mil. Therefore, 908 Devices's FCF Margin % for the quarter that ended in Mar. 2026 was 8.71%.
The historical rank and industry rank for 908 Devices's FCF Margin % or its related term are showing as below:
MASS'
s FCF Margin % Range Over the Past 10 Years
Min: -70.65 Med: -51.5 Max: 15.33
Current: -14.36
During the past 8 years, the highest FCF Margin % of 908 Devices was 15.33%. The lowest was -70.65%. And the median was -51.50%.
MASS's FCF Margin % is ranked worse than 68.59% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs MASS: -14.36
908 Devices FCF Margin % Related Terms
908 Devices FCF Margin % Historical Data
* Premium members only.
The historical data trend for 908 Devices's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 908 Devices's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's FCF Margin % distribution charts can be found below:
* The bar in red indicates where 908 Devices's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
908 Devices (MASS) has a FCF Margin % of 8.71% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 908 Devices and its competitors. According to the industry distribution chart, 908 Devices ranks #559 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 68.6%.
Is 908 Devices' FCF Margin % too high?
908 Devices' current FCF Margin % is 8.71%. Based on the distribution chart, 908 Devices ranks #559 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, 908 Devices has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' FCF Margin % compare to ELMD and SI?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #559 out of 815 companies for FCF Margin %. This places 908 Devices in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 908 Devices and its competitors. 908 Devices's current FCF Margin % is 8.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.91, compared to a current price of $8.98 — trading 30% above its estimated fair value. The current FCF Margin % is 8.71%. 908 Devices' overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For 908 Devices (MASS), the current FCF Margin % is 8.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $8.98 is trading 30% above its estimated GF Value™ of $6.91.
GuruFocus considers 908 Devices to be Modestly Overvalued.
Key valuation signals for MASS:
FCF Margin %: 8.71%
GF Value™: $6.91 vs. price of $8.98 (30% above fair value)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score
Get the complete analysis for MASS
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
